{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T12:37:32Z","timestamp":1793191052487,"version":"4.5.0"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"29","license":[{"start":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T00:00:00Z","timestamp":1594944000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004829","name":"Department of Science and Technology of Sichuan Province","doi-asserted-by":"crossref","award":["2020YFH0164"],"award-info":[{"award-number":["2020YFH0164"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>The use of antibiotics in the acute exacerbations of chronic obstructive pulmonary disease (COPD) remains controversial. Serum C-reactive protein (CRP), a sensitive biomarker for systemic inflammation and tissue damage, is a good indicator of lower respiratory tract bacterial infection. However, due to the small sample size of the existing studies, the clinical value of CRP in guiding the use of acute exacerbation of chronic obstructive pulmonary disease (AECOPD) antibiotics is insufficient. The aim of this study was to evaluate the value of CRP-guided treatment strategies for AECOPD patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This review summarizes and meta-analyses randomized controlled trials (RCTs) of CRP guiding antibiotic prescribing for COPD exacerbations. RCTs compare either usual-care or the GOLD strategy have been included. The following electronic databases have been searched: PubMed, Cochrane Library, Embase, CNKI, CBM, VIP, and Wanfang Data. The methodologic quality of RCTs has been assessed using the Cochrane risk assessment tool. All trials included are analyzed according to the criteria of the Cochrane Handbook. Review Manager 5.3, R-3.5.1 software, and GRADE pro GDT web solution are used for data synthesis and analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>This review evaluates the effects of CRP testing on the antibiotic use, CCQ, EQ-5D utility scores and adverse events in patients with COPD exacerbations.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>This review provides clear evidence that CRP testing can reduce the use of antibiotics in patients with AECOPD without causing harm.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000021152","type":"journal-article","created":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T18:04:37Z","timestamp":1595009077000},"page":"e21152","source":"Crossref","is-referenced-by-count":7,"title":["C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations"],"prefix":"10.1097","volume":"99","author":[{"given":"Xing","family":"An","sequence":"first","affiliation":[{"name":"Respiratory Department, Hospital of Chengdu University of Traditional Chinese Medicine"},{"name":"Clinical Medical College, Chengdu University of Traditional Chinese Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuantao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Respiratory Department, Hospital of Chengdu University of Traditional Chinese Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangwen","family":"Weng","sequence":"additional","affiliation":[{"name":"Clinical Medical College, Chengdu University of Traditional Chinese Medicine"},{"name":"Department of Critical Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xiao","sequence":"additional","affiliation":[{"name":"Respiratory Department, Hospital of Chengdu University of Traditional Chinese Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengtao","family":"Sun","sequence":"additional","affiliation":[{"name":"Respiratory Department, Hospital of Chengdu University of Traditional Chinese Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhu","family":"Zeng","sequence":"additional","affiliation":[{"name":"Respiratory Department, Hospital of Chengdu University of Traditional Chinese Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1878-3579","authenticated-orcid":false,"given":"Qingsong","family":"Huang","sequence":"additional","affiliation":[{"name":"Respiratory Department, Hospital of Chengdu University of Traditional Chinese Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,7,17]]},"reference":[{"key":"R2-20230915","first-page":"g5237","article-title":"Management and prevention of exacerbations of COPD","volume":"349","author":"Aaron","year":"2014","journal-title":"BMJ (Clinical research ed)"},{"key":"R3-20230915","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/thorax.57.10.847","article-title":"Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease","volume":"57","author":"Donaldson","year":"2002","journal-title":"Thorax"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1136\/thx.2005.040527","article-title":"Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease","volume":"60","author":"Soler-Catalu\u00f1a","year":"2005","journal-title":"Thorax"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2147\/COPD.S98333","article-title":"Treatment of patients with COPD and recurrent exacerbations: the role of infection and inflammation","volume":"11","author":"Santos","year":"2016","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"196","DOI":"10.7326\/0003-4819-106-2-196","article-title":"Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease","volume":"106","author":"Anthonisen","year":"1987","journal-title":"Ann Intern Med"},{"key":"R7-20230915","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1378\/chest.13-0518","article-title":"Is it possible to identify exacerbations of mild to moderate COPD that do not require antibiotic treatment?","volume":"144","author":"Miravitlles","year":"2013","journal-title":"Chest"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"54S-e1","DOI":"10.1378\/chest.136.4_MeetingAbstracts.54S-e","article-title":"Inflammatory markers and BMI in patients with exacerbation of COPD","volume":"136","author":"Guleria","year":"2009","journal-title":"Chest"},{"key":"R9-20230915","first-page":"434","article-title":"Diagnostic value of signs, symptoms and laboratory values in lower respiratory tract infection","volume":"136","author":"Stolz","year":"2006","journal-title":"Swiss Med Wkly"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1378\/chest.09-2927","article-title":"Procalcitonin vs C-reactive protein as predictive markers of response to antibiotic therapy in acute exacerbations of COPD","volume":"138","author":"Daniels","year":"2010","journal-title":"Chest"},{"key":"R12-20230915","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ (Clinical research ed)"},{"key":"R13-20230915","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3109\/15412555.2010.510162","article-title":"Antibiotic resistance in sputum isolates of Streptococcus pneumoniae in chronic obstructive pulmonary disease is related to antibiotic exposure","volume":"7","author":"Desai","year":"2010","journal-title":"COPD"},{"key":"R14-20230915","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1172\/JCI200318921","article-title":"C-reactive protein: a critical update","volume":"111","author":"Pepys","year":"2003","journal-title":"J Clin Invest"},{"key":"R15-20230915","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1164\/rccm.201104-0597OC","article-title":"Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers","volume":"184","author":"Bafadhel","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"R16-20230915","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1164\/rccm.201206-0996OC","article-title":"Efficacy of antibiotic therapy for acute exacerbations of mild to moderate chronic obstructive pulmonary disease","author":"Llor","year":"2012","journal-title":"Am J Respir Crit Care Med V 186"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000021152","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T01:31:12Z","timestamp":1694827872000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000021152"}},"subtitle":["A protocol for systematic review and meta-analysis"],"short-title":[],"issued":{"date-parts":[[2020,7,17]]},"references-count":14,"journal-issue":{"issue":"29","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000021152","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,17]]}}}